Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues
December 11th 2023The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.
Read More
FDA Approves Isavuconazonium Sulfate to Treat Invasive Aspergillosis, Invasive Mucormycotic
December 8th 2023The approval marks isavuconazonium sulfate as the only granted azole antifungal therapy for pediatric patients with invasive aspergillosia and invasive mucormycotic who are as young as age 1.
Read More